<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04871685</url>
  </required_header>
  <id_info>
    <org_study_id>Vanvitelli</org_study_id>
    <nct_id>NCT04871685</nct_id>
  </id_info>
  <brief_title>The ECOVITA Study - Validation of LUS Score in SARS-CoV-2 Disease, i.e COVID-19</brief_title>
  <acronym>ECOVITA</acronym>
  <official_title>ECOVITA Study. Observational Study on Sars-COV 2 Population Hospitalized in the Italian Country</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Campania &quot;Luigi Vanvitelli&quot;</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Campania &quot;Luigi Vanvitelli&quot;</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Lung Ultrasound (LUS) has been revealing an extremely useful tool to identify and monitor&#xD;
      complications from Sars-COV-2 disease. Recently, a research group has proposed a score, named&#xD;
      LUS Score, able to optimize the use of this diagnostic technique. LUS Score is computed&#xD;
      analyzing chest posterior and lateral spaces, considering the number of artefacts generated&#xD;
      by the inflammed interstitium (B lines), the characteristics of the pleural line and the&#xD;
      presence or not of consolidation areas.&#xD;
&#xD;
      The comparison between LUS and chest tomography (CT), the current gold standard for the&#xD;
      diagnosis of interstitial pneumonia by COVID-19, has confirmed from the preliminary data, the&#xD;
      reliability of such technique. Hence, the validation on a really large sample size of the&#xD;
      ultrasound tool performed by dedicated personnel with high expertise, may allow the&#xD;
      validation both in the clinical practice and in emergency and ordinary wards.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">October 18, 2020</start_date>
  <completion_date type="Anticipated">May 3, 2021</completion_date>
  <primary_completion_date type="Actual">April 24, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>validation of lung ultrasound score</measure>
    <time_frame>6 months</time_frame>
    <description>validation of lung ultrasound in the clinical practice of diagnosis of complications of low respiratory tracts during COVID-19</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Association of LUS score with clinical outcome</measure>
    <time_frame>6 months</time_frame>
    <description>assessment of LUS score association with the clinical course of disease (final outcome, either discharged or in-hospital mortality</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Association of LUS score with duration of hospitalization (days)</measure>
    <time_frame>6 months</time_frame>
    <description>assessment of LUS score association with hospitalization days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Association of LUS score with respiratory support required</measure>
    <time_frame>6 months</time_frame>
    <description>assessment of LUS score association with requirement of either sub-intensive or intensive therapy)</description>
  </secondary_outcome>
  <number_of_groups>9</number_of_groups>
  <enrollment type="Actual">950</enrollment>
  <condition>Respiratory Distress Syndrome</condition>
  <arm_group>
    <arm_group_label>Covid Center UOC Vanvitelli, Naples</arm_group_label>
    <description>Patients hospitalized due to Sars-Cov-2 disease either in emergency or ordinary medicine/intensive care units</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Covid Center Cotugno Hospital, Naples</arm_group_label>
    <description>Patients hospitalized due to Sars-Cov-2 disease either in emergency or ordinary medicine/intensive care units</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Covid Center &quot;Del Mare Hospital&quot;, Naples</arm_group_label>
    <description>Patients hospitalized due to Sars-Cov-2 disease either in emergency or ordinary medicine/intensive care units</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Covid Center Santa Maria delle Grazie Hospital, Pozzuoli</arm_group_label>
    <description>Patients hospitalized due to Sars-Cov-2 disease either in emergency or ordinary medicine/intensive care units</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Covid Center Monaldi Hospital, Naples</arm_group_label>
    <description>Patients hospitalized due to Sars-Cov-2 disease either in emergency or ordinary medicine/intensive care units</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Covid Center Vannini Hospital, Rome</arm_group_label>
    <description>Patients hospitalized due to Sars-Cov-2 disease either in emergency or ordinary medicine/intensive care units</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Covid Center Bassini Hospital, ASST Milano Nord</arm_group_label>
    <description>Patients hospitalized due to Sars-Cov-2 disease either in emergency or ordinary medicine/intensive care units</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Covid Center Melfi Hospital</arm_group_label>
    <description>Patients hospitalized due to Sars-Cov-2 disease either in emergency or ordinary medicine/intensive care units</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Covid Center Messina University Hospital</arm_group_label>
    <description>Patients hospitalized due to Sars-Cov-2 disease either in emergency or ordinary medicine/intensive care units</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>lung ultrasound</intervention_name>
    <description>the patients underwent to a non invasive diagnostic exam to identify and monitor clinical conditions and onset of respiratory complications due to COVID-19</description>
    <arm_group_label>Covid Center &quot;Del Mare Hospital&quot;, Naples</arm_group_label>
    <arm_group_label>Covid Center Bassini Hospital, ASST Milano Nord</arm_group_label>
    <arm_group_label>Covid Center Cotugno Hospital, Naples</arm_group_label>
    <arm_group_label>Covid Center Melfi Hospital</arm_group_label>
    <arm_group_label>Covid Center Messina University Hospital</arm_group_label>
    <arm_group_label>Covid Center Monaldi Hospital, Naples</arm_group_label>
    <arm_group_label>Covid Center Santa Maria delle Grazie Hospital, Pozzuoli</arm_group_label>
    <arm_group_label>Covid Center UOC Vanvitelli, Naples</arm_group_label>
    <arm_group_label>Covid Center Vannini Hospital, Rome</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patients hospitalized due to COVID19 infection&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  men and women;&#xD;
&#xD;
          -  confirmed COVID19 diagnosis after nasal-oropharyngeal swab;&#xD;
&#xD;
          -  any symptom at hospitalization&#xD;
&#xD;
          -  any therapy&#xD;
&#xD;
          -  any pre-existing comorbidity&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  pregnant women&#xD;
&#xD;
          -  healthy subjects with other respiratory diseases different from COVID-19&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of Campania Luigi Vanvitelli</name>
      <address>
        <city>Naples</city>
        <state>Campania</state>
        <zip>80138</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>April 27, 2021</study_first_submitted>
  <study_first_submitted_qc>May 1, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 4, 2021</study_first_posted>
  <last_update_submitted>May 1, 2021</last_update_submitted>
  <last_update_submitted_qc>May 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Campania &quot;Luigi Vanvitelli&quot;</investigator_affiliation>
    <investigator_full_name>Luca Rinaldi</investigator_full_name>
    <investigator_title>Researcher</investigator_title>
  </responsible_party>
  <keyword>lung ultrasound</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Distress Syndrome</mesh_term>
    <mesh_term>Respiratory Distress Syndrome, Newborn</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

